R

Rubik Therapeutics

3 employees

Rubik Therapeutics is leveraging computational biology and genome-wide screens to develop engineered cell therapies for solid tumors.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2020

Funding rounds raised

R

Rubik Therapeutics raised undisclosed on February 8, 2021

Investors: Illumina For Startups

FAQ